These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 26362760

  • 1. Utility of component analyses in subjects undergoing sublingual immunotherapy for peanut allergy.
    Burk CM, Kulis M, Leung N, Kim EH, Burks AW, Vickery BP.
    Clin Exp Allergy; 2016 Feb; 46(2):347-53. PubMed ID: 26362760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The value of specific IgE to peanut and its component Ara h 2 in the diagnosis of peanut allergy.
    Lopes de Oliveira LC, Aderhold M, Brill M, Schulz G, Rolinck-Werninghaus C, Clare Mills EN, Niggemann B, Naspitz CK, Wahn U, Beyer K.
    J Allergy Clin Immunol Pract; 2013 Feb; 1(4):394-8. PubMed ID: 24565545
    [Abstract] [Full Text] [Related]

  • 4. Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy.
    Ackerbauer D, Bublin M, Radauer C, Varga EM, Hafner C, Ebner C, Szépfalusi Z, Fröschl R, Hoffmann-Sommergruber K, Eiwegger T, Breiteneder H.
    Int Arch Allergy Immunol; 2015 Feb; 166(1):13-24. PubMed ID: 25765158
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Utility of specific IgE to Ara h 6 in peanut allergy diagnosis.
    Pedrosa M, Boyano-Martínez T, García-Ara C, Caballero T, Quirce S.
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):108-12. PubMed ID: 26073164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy.
    Wood RA, Sicherer SH, Burks AW, Grishin A, Henning AK, Lindblad R, Stablein D, Sampson HA.
    Allergy; 2013 Jun; 68(6):803-8. PubMed ID: 23621498
    [Abstract] [Full Text] [Related]

  • 9. Long-term sublingual immunotherapy for peanut allergy in children: Clinical and immunologic evidence of desensitization.
    Kim EH, Yang L, Ye P, Guo R, Li Q, Kulis MD, Burks AW.
    J Allergy Clin Immunol; 2019 Nov; 144(5):1320-1326.e1. PubMed ID: 31493887
    [Abstract] [Full Text] [Related]

  • 10. IgE, but not IgG4, antibodies to Ara h 2 distinguish peanut allergy from asymptomatic peanut sensitization.
    Hong X, Caruso D, Kumar R, Liu R, Liu X, Wang G, Pongracic JA, Wang X.
    Allergy; 2012 Dec; 67(12):1538-46. PubMed ID: 23094689
    [Abstract] [Full Text] [Related]

  • 11. Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area.
    Garcia-Blanca A, Aranda A, Blanca-Lopez N, Perez D, Gomez F, Mayorga C, Torres MJ, Diaz-Perales A, Perkins JR, Villalba M, Blanca M, Canto G.
    Pediatr Allergy Immunol; 2015 Sep; 26(6):497-502. PubMed ID: 26046378
    [Abstract] [Full Text] [Related]

  • 12. Ara h 2 is the dominant peanut allergen despite similarities with Ara h 6.
    Hemmings O, Du Toit G, Radulovic S, Lack G, Santos AF.
    J Allergy Clin Immunol; 2020 Sep; 146(3):621-630.e5. PubMed ID: 32298698
    [Abstract] [Full Text] [Related]

  • 13. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK, Pelkonen AS, Mäkinen-Kiljunen S, Voutilainen H, Mäkelä MJ.
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [Abstract] [Full Text] [Related]

  • 14. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
    Glaumann S, Nopp A, Johansson SG, Rudengren M, Borres MP, Nilsson C.
    Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
    [Abstract] [Full Text] [Related]

  • 15. Ara h 1 and Ara h 6 Sensitization Causes Clinical Peanut Allergy in Ara h 2-Negative Individuals.
    Magnusdottir H, Vidarsdóttir AG, Ludviksson BR, Clausen M, Lund SH, Jensen AB, Sigurdardottir ST.
    Int Arch Allergy Immunol; 2019 Feb; 178(1):66-75. PubMed ID: 30368492
    [Abstract] [Full Text] [Related]

  • 16. Measurement of Ara h 1-, 2-, and 3-specific IgE antibodies is useful in diagnosis of peanut allergy in Japanese children.
    Ebisawa M, Movérare R, Sato S, Maruyama N, Borres MP, Komata T.
    Pediatr Allergy Immunol; 2012 Sep; 23(6):573-81. PubMed ID: 22831547
    [Abstract] [Full Text] [Related]

  • 17. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.
    Dreskin SC, Germinaro M, Reinhold D, Chen X, Vickery BP, Kulis M, Burks AW, Negi SS, Braun W, Chambliss JM, Eglite S, McNulty CMG.
    Pediatr Allergy Immunol; 2019 Dec; 30(8):817-823. PubMed ID: 31437325
    [Abstract] [Full Text] [Related]

  • 18. Single B-cell deconvolution of peanut-specific antibody responses in allergic patients.
    Hoh RA, Joshi SA, Liu Y, Wang C, Roskin KM, Lee JY, Pham T, Looney TJ, Jackson KJL, Dixit VP, King J, Lyu SC, Jenks J, Hamilton RG, Nadeau KC, Boyd SD.
    J Allergy Clin Immunol; 2016 Jan; 137(1):157-167. PubMed ID: 26152318
    [Abstract] [Full Text] [Related]

  • 19. Natural clinical tolerance to peanut in African patients is caused by poor allergenic activity of peanut IgE.
    Wollmann E, Hamsten C, Sibanda E, Ochome M, Focke-Tejkl M, Asarnoj A, Önell A, Lilja G, Gallerano D, Lupinek C, Thalhamer T, Weiss R, Thalhamer J, Wickman M, Valenta R, van Hage M.
    Allergy; 2015 Jun; 70(6):638-52. PubMed ID: 25683061
    [Abstract] [Full Text] [Related]

  • 20. Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.
    Kim EH, Bird JA, Keet CA, Virkud YV, Herlihy L, Ye P, Smeekens JM, Guo R, Yue X, Penumarti A, Qaqish B, Li Q, Kulis MD, Burks AW.
    J Allergy Clin Immunol; 2024 Jan; 153(1):173-181.e10. PubMed ID: 37815782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.